Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders.

× No keyword cloud information.

16 in total

1. Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty.

Authors: F Minuto; A Barreca; P Del Monte; P Fortini; M Resentini; F Morabito; G Giordano
Journal: J Endocrinol Invest Date: 1988 Jul-Aug Impact factor: 4.256

2. Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I.

Authors: A Kurtz; W Härtl; W Jelkmann; J Zapf; C Bauer
Journal: J Clin Invest Date: 1985-10 Impact factor: 14.808

3. Insulin exerts metabolic and growth-promoting effects by a direct action on the liver in vivo: clarification of the functional significance of the portal vascular link between the beta cells of the pancreatic islets and the liver.

Authors: S C Griffen; S M Russell; L S Katz; C S Nicoll
Journal: Proc Natl Acad Sci U S A Date: 1987-10 Impact factor: 11.205

Review 4. [Principles and clinical significance of insulin-like growth factors/somatomedins].

Authors: E Weimann; W Kiess
Journal: Klin Wochenschr Date: 1990-10-17

5. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.

Authors: J Zapf; C Schmid; H P Guler; M Waldvogel; C Hauri; E Futo; P Hossenlopp; M Binoux; E R Froesch
Journal: J Clin Invest Date: 1990-09 Impact factor: 14.808

10. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.

Authors: Robert E Schmidt; Denise A Dorsey; Lucie N Beaudet; Richard G Peterson
Journal: Am J Pathol Date: 2003-07 Impact factor: 4.307

Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders.

1. Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty.

2. Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I.

3. Insulin exerts metabolic and growth-promoting effects by a direct action on the liver in vivo: clarification of the functional significance of the portal vascular link between the beta cells of the pancreatic islets and the liver.

Review 4. [Principles and clinical significance of insulin-like growth factors/somatomedins].

5. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.

6. Insulin-like growth factors and insulin: comparative aspects.

7. Structure of the insulin-like growth factor receptor in chicken embryo fibroblasts.

8. Regulation of insulin-like growth factor I gene expression by growth hormone.

9. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis.

10. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.